Anika Therapeutics (ANIK) Net Income Growth (3y) (2013 - 2025)
Anika Therapeutics (ANIK) Net Income Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.86 Bn | 88.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.98 Bn | 32.24 Bn | 1.97 Bn | 51.28% |
| 3 | Zoetis | 32.48 Bn | 30.54 Bn | 1.62 Bn | 2.94% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | -62.58% |
| 5 | United Therapeutics | 23.01 Bn | 20.86 Bn | 648.10 Mn | 4.50% |
| 6 | RedHill Biopharma | 22.02 Bn | 22.02 Bn | - | - |
| 7 | Viatris | 20.40 Bn | 18.59 Bn | 1.16 Bn | -7.75% |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.46 Bn | 800.70 Mn | 66.11% |
| 9 | Elanco Animal Health | 12.74 Bn | 12.31 Bn | 785.00 Mn | -17.90% |
| 10 | Anika Therapeutics | 203.37 Mn | 136.58 Mn | 19.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -28.55% |
| Sep 30, 2025 | 30.11% |
| Jun 30, 2025 | 30.81% |
| Mar 31, 2025 | 32.18% |
| Dec 31, 2024 | -21.82% |
| Sep 30, 2024 | -275.29% |
| Jun 30, 2024 | -27.85% |
| Mar 31, 2024 | -42.63% |
| Dec 31, 2023 | 15.46% |
| Sep 30, 2023 | -0.43% |
| Jun 30, 2023 | 28.89% |
| Mar 31, 2023 | -55.87% |
| Dec 31, 2022 | 25.08% |
| Sep 30, 2022 | -34.85% |
| Jun 30, 2022 | -32.03% |
| Mar 31, 2022 | -38.40% |
| Dec 31, 2021 | -48.54% |
| Sep 30, 2021 | -58.28% |
| Jun 30, 2021 | -13.51% |
| Mar 31, 2021 | 34.34% |